HCW Biologics Inc.(HCWB)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

HCWB HCW Biologics Inc.

交易中 12-15 13:30:28 EST

1.80

-0.01

-0.55%

最高1.83	最低1.77	成交量1.12万
今开1.83	昨收1.81	日振幅3.31%
总市值486.29万	流通市值233.17万	总股本270.16万
成交额2.01万	换手率0.86%	流通股本129.54万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"HCWB","market":"US","secType":"STK","nameCN":"HCW Biologics Inc.","latestPrice":1.8,"timestamp":1765822929691,"preClose":1.81,"halted":0,"volume":11174,"delay":0,"floatShares":1295400,"shares":2701607,"eps":-17.5946,"marketStatus":"交易中","change":-0.01,"latestTime":"12-15 13:30:28 EST","open":1.83,"high":1.83,"low":1.77,"amount":20073.5010128,"amplitude":0.033149,"askPrice":1.84,"askSize":146,"bidPrice":1.78,"bidSize":3,"shortable":0,"etf":0,"ttmEps":-17.5946,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1765832400000},"marketStatusCode":2,"adr":0,"listingDate":1626753600000,"exchange":"NASDAQ","adjPreClose":1.81,"preHourTrading":{"tag":"盘前","latestPrice":1.84,"preClose":1.81,"latestTime":"09:24 EST","volume":355,"amount":643.685787,"timestamp":1765808665613},"postHourTrading":{"tag":"盘后","latestPrice":1.81,"preClose":1.81,"latestTime":"19:45 EST","volume":193,"amount":349.52,"timestamp":1765586746495},"volumeRatio":0.228026},"requestUrl":"/m/hq/s/HCWB","defaultTab":"news","newsList":[{"id":"1105799590","title":"HCW Biologics启动首个针对自身免疫疾病的HCW9302人类临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1105799590","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1105799590?lang=zh_cn&edition=full","pubTime":"2025-11-18 20:25","pubTimestamp":1763468744,"startTime":"0","endTime":"0","summary":"HCW Biologics启动首个针对自身免疫疾病的HCW9302人类临床试验","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HCWB","BK4539","BK4139"],"gpt_icon":0},{"id":"2584757620","title":"Hcw Biologics Inc.盘中异动 早盘急速下挫13.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584757620","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584757620?lang=zh_cn&edition=full","pubTime":"2025-11-17 22:31","pubTimestamp":1763389889,"startTime":"0","endTime":"0","summary":"北京时间2025年11月17日22时31分，Hcw Biologics Inc.股票出现波动，股价大幅下跌13.00%。Hcw Biologics Inc.股票所在的生物技术行业中，整体涨幅为0.38%。Hcw Biologics Inc.公司简介：HCW Biologics Inc是一家临床阶段的生物制药公司，专注于发现和开发新型免疫疗法，通过打破慢性低度炎症与与年龄相关疾病之间的联系，延长健康寿命。它已选择了两种分子作为其产品候选药物；HCW9218和HCW9302。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117223129976f113e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117223129976f113e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HCWB","BK4139","BK4539"],"gpt_icon":0},{"id":"2575093277","title":"Hcw Biologics Inc.盘中异动 早盘股价大涨5.69%报4.46美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2575093277","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575093277?lang=zh_cn&edition=full","pubTime":"2025-10-14 23:28","pubTimestamp":1760455698,"startTime":"0","endTime":"0","summary":"北京时间2025年10月14日23时28分，Hcw Biologics Inc.股票出现波动，股价大幅上涨5.69%。截至发稿，该股报4.46美元/股，成交量1.9525万股，换手率0.91%，振幅5.45%。Hcw Biologics Inc.股票所在的生物技术行业中，整体涨幅为0.20%。Hcw Biologics Inc.公司简介：HCW Biologics Inc是一家临床阶段的生物制药公司，专注于发现和开发新型免疫疗法，通过打破慢性低度炎症与与年龄相关疾病之间的联系，延长健康寿命。它已选择了两种分子作为其产品候选药物；HCW9218和HCW9302。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251014232818a45fd739&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251014232818a45fd739&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HCWB","BK4139","BK4539"],"gpt_icon":0},{"id":"2562225367","title":"美股异动 | 推出下一代癌症免疫治疗平台 HCW Biologics(HCWB.US)暴涨近70%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562225367","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562225367?lang=zh_cn&edition=full","pubTime":"2025-08-25 23:21","pubTimestamp":1756135279,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周一，HCW Biologics(HCWB.US)暴涨近70%，报5.81美元。消息面上，该公司报告称，其科学家已开发出第二代基于帕博利珠单抗的免疫治疗药物，针对实体肿瘤，特别是胰腺癌和卵巢癌，采用其新颖的专有TRBC产品发现和开发平台技术。自2011年引入癌症治疗以来，免疫检查点抑制剂(ICIs)被誉为突破性的癌症疗法。免疫检查点蛋白在T细胞表面表达，作为抑制T细胞过度激活的调节因子。然而，该公司周一指出的临床前和临床研究表明，ICIs缺乏免疫细胞共刺激活性，从而降低了其抗肿瘤疗效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1334935.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"美股异动 | 推出下一代癌症免疫治疗平台 HCW Biologics(HCWB.US)暴涨近70%","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4139","BK4539","HCWB"],"gpt_icon":0},{"id":"2558866989","title":"Hcw Biologics Inc.盘中异动 早盘急速跳水5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558866989","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558866989?lang=zh_cn&edition=full","pubTime":"2025-08-11 22:39","pubTimestamp":1754923154,"startTime":"0","endTime":"0","summary":"北京时间2025年08月11日22时39分，Hcw Biologics Inc.股票出现异动，股价急速下挫5.19%。Hcw Biologics Inc.股票所在的生物技术行业中，整体涨幅为0.36%。Hcw Biologics Inc.公司简介：HCW Biologics Inc是一家临床阶段的生物制药公司，专注于发现和开发新型免疫疗法，通过打破慢性低度炎症与与年龄相关疾病之间的联系，延长健康寿命。它已选择了两种分子作为其产品候选药物；HCW9218和HCW9302。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081122391594dcd9c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081122391594dcd9c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","HCWB"],"gpt_icon":0},{"id":"2557578302","title":"Hcw Biologics Inc.盘中异动 股价大跌5.76%报4.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557578302","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557578302?lang=zh_cn&edition=full","pubTime":"2025-08-08 21:55","pubTimestamp":1754661352,"startTime":"0","endTime":"0","summary":"北京时间2025年08月08日21时55分，Hcw Biologics Inc.股票出现波动，股价快速下挫5.76%。截至发稿，该股报4.25美元/股，成交量1396股，换手率0.05%，振幅4.43%。Hcw Biologics Inc.股票所在的生物技术行业中，整体跌幅为0.24%。Hcw Biologics Inc.公司简介：HCW Biologics Inc是一家临床阶段的生物制药公司，专注于发现和开发新型免疫疗法，通过打破慢性低度炎症与与年龄相关疾病之间的联系，延长健康寿命。它已选择了两种分子作为其产品候选药物；HCW9218和HCW9302。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080821555294d7d30a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080821555294d7d30a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","HCWB"],"gpt_icon":0},{"id":"2557316350","title":"Hcw Biologics Inc.盘中异动 下午盘股价大涨5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557316350","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557316350?lang=zh_cn&edition=full","pubTime":"2025-08-06 01:48","pubTimestamp":1754416095,"startTime":"0","endTime":"0","summary":"北京时间2025年08月06日01时48分，Hcw Biologics Inc.股票出现波动，股价大幅拉升5.36%。Hcw Biologics Inc.股票所在的生物技术行业中，整体跌幅为3.70%。Hcw Biologics Inc.公司简介：HCW Biologics Inc是一家临床阶段的生物制药公司，专注于发现和开发新型免疫疗法，通过打破慢性低度炎症与与年龄相关疾病之间的联系，延长健康寿命。它已选择了两种分子作为其产品候选药物；HCW9218和HCW9302。HCW9302目的在激活和扩张调节性T细胞，从而使炎症小体失活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080601481694d1bb2e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080601481694d1bb2e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HCWB","BK4539","BK4139"],"gpt_icon":0},{"id":"2555265057","title":"Hcw Biologics Inc.盘中异动 早盘急速上涨6.47%报4.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555265057","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555265057?lang=zh_cn&edition=full","pubTime":"2025-07-29 21:56","pubTimestamp":1753797402,"startTime":"0","endTime":"0","summary":"北京时间2025年07月29日21时56分，Hcw Biologics Inc.股票出现波动，股价大幅拉升6.47%。截至发稿，该股报4.42美元/股，成交量4643股，换手率0.18%，振幅2.20%。Hcw Biologics Inc.股票所在的生物技术行业中，整体涨幅为0.03%。Hcw Biologics Inc.公司简介：HCW Biologics Inc是一家临床阶段的生物制药公司，专注于发现和开发新型免疫疗法，通过打破慢性低度炎症与与年龄相关疾病之间的联系，延长健康寿命。它已选择了两种分子作为其产品候选药物；HCW9218和HCW9302。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072921564297258f69&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072921564297258f69&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","HCWB","BK4539"],"gpt_icon":0},{"id":"2554777217","title":"Hcw Biologics Inc.盘中异动 大幅跳水5.40%报4.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2554777217","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554777217?lang=zh_cn&edition=full","pubTime":"2025-07-28 21:30","pubTimestamp":1753709456,"startTime":"0","endTime":"0","summary":"北京时间2025年07月28日21时30分，Hcw Biologics Inc.股票出现异动，股价大幅跳水5.40%。截至发稿，该股报4.03美元/股，成交量287股，换手率0.01%，振幅0.00%。Hcw Biologics Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Hcw Biologics Inc.公司简介：HCW Biologics Inc是一家临床阶段的生物制药公司，专注于发现和开发新型免疫疗法，通过打破慢性低度炎症与与年龄相关疾病之间的联系，延长健康寿命。它已选择了两种分子作为其产品候选药物；HCW9218和HCW9302。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728213057a467d907&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728213057a467d907&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HCWB","BK4139","BK4539"],"gpt_icon":0},{"id":"2552124918","title":"Hcw Biologics Inc.盘中异动 股价大涨6.29%报4.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552124918","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552124918?lang=zh_cn&edition=full","pubTime":"2025-07-17 00:14","pubTimestamp":1752682441,"startTime":"0","endTime":"0","summary":"北京时间2025年07月17日00时14分，Hcw Biologics Inc.股票出现异动，股价大幅拉升6.29%。截至发稿，该股报4.63美元/股，成交量8765股，换手率0.35%，振幅5.20%。Hcw Biologics Inc.股票所在的生物技术行业中，整体涨幅为1.35%。Hcw Biologics Inc.公司简介：HCW Biologics Inc是一家临床阶段的生物制药公司，专注于发现和开发新型免疫疗法，通过打破慢性低度炎症与与年龄相关疾病之间的联系，延长健康寿命。它已选择了两种分子作为其产品候选药物；HCW9218和HCW9302。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717001401a44f1da9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717001401a44f1da9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HCWB","BK4139","BK4539"],"gpt_icon":0},{"id":"2550650403","title":"Hcw Biologics Inc.盘中异动 大幅拉升6.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550650403","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550650403?lang=zh_cn&edition=full","pubTime":"2025-07-10 02:51","pubTimestamp":1752087083,"startTime":"0","endTime":"0","summary":"北京时间2025年07月10日02时51分，Hcw Biologics Inc.股票出现波动，股价快速上涨6.31%。Hcw Biologics Inc.股票所在的生物技术行业中，整体涨幅为1.27%。Hcw Biologics Inc.公司简介：HCW Biologics Inc是一家临床阶段的生物制药公司，专注于发现和开发新型免疫疗法，通过打破慢性低度炎症与与年龄相关疾病之间的联系，延长健康寿命。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710025123979ff7fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710025123979ff7fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","HCWB"],"gpt_icon":0},{"id":"2542503865","title":"Hcw Biologics Inc.6月11日成交额为12.34万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542503865","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542503865?lang=zh_cn&edition=full","pubTime":"2025-06-12 10:17","pubTimestamp":1749694660,"startTime":"0","endTime":"0","summary":"美东时间2025年6月11日，Hcw Biologics Inc.成交额为12.34万美元，成交额较昨日减少50.15%，当日成交量为2.33万股。Hcw Biologics Inc.于2025年6月11日跌4.92%，报5.22美元，该股过去5个交易日跌14.98%，年初至今跌70.74%，过去60日跌61.5%。它已选择了两种分子作为其产品候选药物；HCW9218和HCW9302。HCW9218是一种双功能免疫疗法，具有中和转化生长的能力并刺激免疫细胞。HCW9302目的在激活和扩张调节性T细胞，从而使炎症小体失活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612101746a7046c29&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612101746a7046c29&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HCWB"],"gpt_icon":0},{"id":"2542332016","title":"Hcw Biologics Inc.6月10日成交额为24.75万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542332016","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542332016?lang=zh_cn&edition=full","pubTime":"2025-06-11 10:09","pubTimestamp":1749607763,"startTime":"0","endTime":"0","summary":"美东时间2025年6月10日，Hcw Biologics Inc.成交额为24.75万美元，成交额较昨日增加31.22%，当日成交量为4.42万股。Hcw Biologics Inc.于2025年6月10日跌1.61%，报5.49美元，该股过去5个交易日跌18.06%，年初至今跌69.23%，过去60日跌59.63%。它已选择了两种分子作为其产品候选药物；HCW9218和HCW9302。HCW9218是一种双功能免疫疗法，具有中和转化生长的能力并刺激免疫细胞。HCW9302目的在激活和扩张调节性T细胞，从而使炎症小体失活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611100929a4a2bee6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611100929a4a2bee6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HCWB"],"gpt_icon":0},{"id":"2542350659","title":"Hcw Biologics Inc.6月9日成交额为18.86万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542350659","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542350659?lang=zh_cn&edition=full","pubTime":"2025-06-10 10:08","pubTimestamp":1749521286,"startTime":"0","endTime":"0","summary":"美东时间2025年6月9日，Hcw Biologics Inc.成交额为18.86万美元，成交额较昨日增加19.14%，当日成交量为3.25万股。Hcw Biologics Inc.于2025年6月9日跌7.62%，报5.58美元，该股过去5个交易日跌22.61%，年初至今跌68.72%，过去60日跌58.23%。它已选择了两种分子作为其产品候选药物；HCW9218和HCW9302。HCW9218是一种双功能免疫疗法，具有中和转化生长的能力并刺激免疫细胞。HCW9302目的在激活和扩张调节性T细胞，从而使炎症小体失活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610100807a4a12f5c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610100807a4a12f5c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HCWB"],"gpt_icon":0},{"id":"2541885966","title":"Hcw Biologics Inc.6月5日成交额为27.34万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2541885966","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541885966?lang=zh_cn&edition=full","pubTime":"2025-06-06 10:07","pubTimestamp":1749175647,"startTime":"0","endTime":"0","summary":"美东时间2025年6月5日，Hcw Biologics Inc.成交额为27.34万美元，成交额较昨日减少65.23%，当日成交量为4.37万股。Hcw Biologics Inc.于2025年6月5日跌3.09%，报5.95美元，该股过去5个交易日跌25.81%，年初至今跌66.65%，过去60日跌57.38%。它已选择了两种分子作为其产品候选药物；HCW9218和HCW9302。HCW9218是一种双功能免疫疗法，具有中和转化生长的能力并刺激免疫细胞。HCW9302目的在激活和扩张调节性T细胞，从而使炎症小体失活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250606100731a6fc8b49&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250606100731a6fc8b49&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HCWB"],"gpt_icon":0},{"id":"2541019254","title":"Hcw Biologics Inc.6月4日成交额为78.63万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2541019254","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541019254?lang=zh_cn&edition=full","pubTime":"2025-06-05 10:07","pubTimestamp":1749089235,"startTime":"0","endTime":"0","summary":"美东时间2025年6月4日，Hcw Biologics Inc.成交额为78.63万美元，成交额较昨日增加273.14%，当日成交量为12.50万股。Hcw Biologics Inc.于2025年6月4日跌8.36%，报6.14美元，该股过去5个交易日跌23.25%，年初至今跌65.58%，过去60日跌57.24%。它已选择了两种分子作为其产品候选药物；HCW9218和HCW9302。HCW9218是一种双功能免疫疗法，具有中和转化生长的能力并刺激免疫细胞。HCW9302目的在激活和扩张调节性T细胞，从而使炎症小体失活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250605100720a6fb0589&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250605100720a6fb0589&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HCWB"],"gpt_icon":0},{"id":"2540828340","title":"Hcw Biologics Inc.6月3日成交额为21.07万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2540828340","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540828340?lang=zh_cn&edition=full","pubTime":"2025-06-04 10:07","pubTimestamp":1749002823,"startTime":"0","endTime":"0","summary":"美东时间2025年6月3日，Hcw Biologics Inc.成交额为21.07万美元，成交额较昨日增加15.10%，当日成交量为3.10万股。Hcw Biologics Inc.于2025年6月3日跌7.07%，报6.7美元，该股过去5个交易日跌16.25%，年初至今跌62.44%，过去60日跌54.11%。它已选择了两种分子作为其产品候选药物；HCW9218和HCW9302。HCW9218是一种双功能免疫疗法，具有中和转化生长的能力并刺激免疫细胞。HCW9302目的在激活和扩张调节性T细胞，从而使炎症小体失活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250604100705a4991bf5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250604100705a4991bf5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HCWB"],"gpt_icon":0},{"id":"2540245710","title":"Hcw Biologics Inc.6月2日成交额为18.31万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2540245710","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540245710?lang=zh_cn&edition=full","pubTime":"2025-06-03 10:07","pubTimestamp":1748916420,"startTime":"0","endTime":"0","summary":"美东时间2025年6月2日，Hcw Biologics Inc.成交额为18.31万美元，成交额较昨日减少90.78%，当日成交量为2.49万股。Hcw Biologics Inc.于2025年6月2日跌6.73%，报7.21美元，该股过去5个交易日跌13.86%，年初至今跌59.59%，过去60日跌49.23%。它已选择了两种分子作为其产品候选药物；HCW9218和HCW9302。HCW9218是一种双功能免疫疗法，具有中和转化生长的能力并刺激免疫细胞。HCW9302目的在激活和扩张调节性T细胞，从而使炎症小体失活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603100711a49779ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603100711a49779ec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HCWB"],"gpt_icon":0},{"id":"2539201404","title":"Hcw Biologics Inc.5月30日成交额为198.69万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2539201404","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539201404?lang=zh_cn&edition=full","pubTime":"2025-05-31 10:05","pubTimestamp":1748657127,"startTime":"0","endTime":"0","summary":"美东时间2025年5月30日，Hcw Biologics Inc.成交额为198.69万美元，成交额较昨日增加320.87%，当日成交量为24.15万股。Hcw Biologics Inc.于2025年5月30日跌3.62%，报7.73美元，该股过去5个交易日跌6.98%，年初至今跌56.67%，过去60日跌42.99%。它已选择了两种分子作为其产品候选药物；HCW9218和HCW9302。HCW9218是一种双功能免疫疗法，具有中和转化生长的能力并刺激免疫细胞。HCW9302目的在激活和扩张调节性T细胞，从而使炎症小体失活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250531100537a6f414c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250531100537a6f414c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HCWB"],"gpt_icon":0},{"id":"2539215878","title":"Hcw Biologics Inc.5月29日成交额为47.21万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2539215878","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539215878?lang=zh_cn&edition=full","pubTime":"2025-05-30 10:04","pubTimestamp":1748570698,"startTime":"0","endTime":"0","summary":"美东时间2025年5月29日，Hcw Biologics Inc.成交额为47.21万美元，成交额较昨日增加2.71%，当日成交量为5.89万股。Hcw Biologics Inc.于2025年5月29日涨0.25%，报8.02美元，该股过去5个交易日跌7.82%，年初至今跌55.04%，过去60日跌43.84%。它已选择了两种分子作为其产品候选药物；HCW9218和HCW9302。HCW9218是一种双功能免疫疗法，具有中和转化生长的能力并刺激免疫细胞。HCW9302目的在激活和扩张调节性T细胞，从而使炎症小体失活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250530100459a4921813&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250530100459a4921813&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HCWB"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.hcwbiologics.com","stockEarnings":[{"period":"1week","weight":-0.0859},{"period":"1month","weight":-0.3038},{"period":"3month","weight":-0.6762},{"period":"6month","weight":-0.6679},{"period":"1year","weight":-0.8831},{"period":"ytd","weight":-0.8986}],"compareEarnings":[{"period":"1week","weight":-0.0057},{"period":"1month","weight":-0.0024},{"period":"3month","weight":0.037},{"period":"6month","weight":0.142},{"period":"1year","weight":0.1281},{"period":"ytd","weight":0.1633}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"HCW Biologics Inc.于2018年4月2日在特拉华州注册成立。该公司是一家临床阶段的生物制药公司，专注于发现和开发新型免疫疗法，通过中断慢性、低度炎症和与年龄相关的疾病之间的联系来延长健康跨度。该公司认为，与年龄相关的慢性低度炎症或“炎症”是导致几种疾病和状况的重要因素，例如癌症、心血管疾病、糖尿病、神经退行性疾病和自身免疫性疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.125505},{"month":2,"riseRate":0.75,"avgChangeRate":0.149026},{"month":3,"riseRate":0.5,"avgChangeRate":-0.010659},{"month":4,"riseRate":0.25,"avgChangeRate":-0.1522},{"month":5,"riseRate":0.25,"avgChangeRate":-0.089644},{"month":6,"riseRate":0.5,"avgChangeRate":-0.08481},{"month":7,"riseRate":0.5,"avgChangeRate":0.007222},{"month":8,"riseRate":0.4,"avgChangeRate":-0.025444},{"month":9,"riseRate":0.4,"avgChangeRate":-0.08752},{"month":10,"riseRate":0.4,"avgChangeRate":0.021722},{"month":11,"riseRate":0.2,"avgChangeRate":-0.225966},{"month":12,"riseRate":0.2,"avgChangeRate":-0.070267}],"exchange":"NASDAQ","name":"HCW Biologics Inc.","nameEN":"HCW Biologics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"HCW Biologics Inc.(HCWB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供HCW Biologics Inc.(HCWB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"HCW Biologics Inc.,HCWB,HCW Biologics Inc.股票,HCW Biologics Inc.股票老虎,HCW Biologics Inc.股票老虎国际,HCW Biologics Inc.行情,HCW Biologics Inc.股票行情,HCW Biologics Inc.股价,HCW Biologics Inc.股市,HCW Biologics Inc.股票价格,HCW Biologics Inc.股票交易,HCW Biologics Inc.股票购买,HCW Biologics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"HCW Biologics Inc.(HCWB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供HCW Biologics Inc.(HCWB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}